These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24480636)

  • 21. Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients.
    Suh DC; Lee DH; McGuire M; Kim CM
    Curr Med Res Opin; 2011 Aug; 27(8):1623-33. PubMed ID: 21696266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria.
    Awodele O; Osuolale JA
    Afr Health Sci; 2015 Jun; 15(2):513-22. PubMed ID: 26124798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting.
    Davis SN; Wei W; Garg S
    Endocr Pract; 2011; 17(6):845-52. PubMed ID: 21550952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral antidiabetic medication adherence and glycemic control in managed care.
    Rozenfeld Y; Hunt JS; Plauschinat C; Wong KS
    Am J Manag Care; 2008 Feb; 14(2):71-5. PubMed ID: 18269302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.
    Skinner JS; Poe B; Hopper R; Boyer A; Wilkins CH
    Diabetes Educ; 2015 Aug; 41(4):459-65. PubMed ID: 26009557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes.
    de Vries McClintock HF; Morales KH; Small DS; Bogner HR
    Behav Med; 2016; 42(2):63-71. PubMed ID: 24673362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States.
    Durden E; Lenhart G; Lopez-Gonzalez L; Hammer M; Langer J
    J Med Econ; 2016; 19(4):403-13. PubMed ID: 26653068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Factors Affecting Glucose Monitoring Treatment Satisfaction and Drug Attitude Inventory (Adherence) Among Patients with Type 2 Diabetes Mellitus; Cross-sectional Observational Study.
    Rahman SAU
    Curr Diabetes Rev; 2019; 15(3):233-239. PubMed ID: 29618311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States.
    Mody R; Huang Q; Yu M; Zhao R; Patel H; Grabner M; Landó LF
    Diabetes Obes Metab; 2019 Apr; 21(4):920-929. PubMed ID: 30520248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
    Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hot Topics in Primary Care: Medication Adherence in Type 2 Diabetes Mellitus: Real-World Strategies for Addressing a Common Problem.
    Brunton SA; Polonsky WH
    J Fam Pract; 2017 Apr; 66(4 Suppl):S46-S51. PubMed ID: 28375408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Diabetes-related Knowledge and Medication Adherence: Results From Cross-sectional Analysis.
    Nazir SU; Hassali MA; Saleem F; Bashir S; Aljadhey H
    Altern Ther Health Med; 2016 Nov; 22(6):8-13. PubMed ID: 27866175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure is associated with non-adherence to pharmacotherapy in elderly with type 2 diabetes mellitus in public health system Brazilians.
    Peres HA; Leira Pereira LR; Martinez EZ; Viana CM; Foss-Freitas MC
    Diabetes Metab Syndr; 2019; 13(2):939-946. PubMed ID: 31336548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
    Hansen RA; Farley JF; Droege M; Maciejewski ML
    Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.